Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera aims to leverage its unique understanding of autophagy, drug development capabilities, and access to quantum chemistry and generative AI-enabled insights to enhance its drug development programs. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program. The company was founded by co-founders Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs Pte Ltd.
| Website | https://automeratx.com |
| Employees | 12 (7 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Targeted Protein Degradation, Drug Development, Biotechnology, Pharmaceutical Research, Therapeutic Innovation, Precision Medicine, Biopharmaceutical, Life Sciences, Clinical Development, Drug Discovery, Molecular Medicine, Innovative Therapies, Cell Biology, Therapeutic Solutions, Pharmaceutical Development |
| Competitors | Carvana, Turo, Autotrader US, Vroom, TrueCar, Inc., Shift, Cazoo, TRED, Digital Motors, Drive Motors +38 more (view full list) |
Looking for a particular Automera employee's phone or email?
Automera Questions
Mitchell Hymowitz is the CFO of Automera.
7 people are employed at Automera.
Top Automera Employees
-
Mitchell Hymowitz
Chief Financial Officer at Automera
Seattle, WA, US35+ -
22
-
Pearly Ng
Head of Chemistry at Automera
Singapore11 -
Kenrick Yap
Head of Platform at Automera
Singapore1 -
Nazihah Beevi
Senior Research Officer at Automera
San Diego, CA, US1 -
Xi Wong
Scientist (Medicinal Chemistry) at Automera
Subang Jaya, MY1
Related Companies
